Jubilant Life Sciences receives revision in credit ratings from CRISIL
Jubilant Life Sciences announced that CRISIL has assigned the following ratings to the company's facilities -
Long term rating for bank loan facilities (Rs 510 crore) - CRISIL AA (Placed on 'Rating Watch with Developing Implications')
Non-Convertible Debentures (Rs 350 crore) - CRISIL AA (Continues on 'Rating Watch with Developing Implications') (Rating withdrawn as NCDs have been fully redeemed)
Commercial Paper Programme (Rs 400 crore) - CRISIL A1+ (Reaffirmed)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 10 2020 | 12:17 PM IST